Lisanti Capital Growth, LLC Vericel Corp Transaction History

Lisanti Capital Growth, LLC

$297 Million
Q1 2025

A detailed history of Lisanti Capital Growth, LLC transactions in Vericel Corp stock. As of the latest transaction made, Lisanti Capital Growth, LLC holds 39,015 shares of VCEL stock, worth $1.6 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares

39,015

Previous 25,430 53.42%

Holding current value

$1.6 Million

Previous $1.4 Million 24.64%

% of portfolio

0.59%

Previous 0.38%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 24, 2025	BUY	$44.5 - $61.8 $604,532 - $839,553	13,585 Added 53.42%	39,015 $1.74 Million
Q4 2024 Feb 06, 2025	SELL	$40.05 - $59.11 $1.08 Million - $1.6 Million	-27,015 Reduced 51.51%	25,430 $1.4 Million
Q3 2024 Nov 04, 2024	SELL	$42.25 - $53.56 $2.64 Million - $3.35 Million	-62,545 Reduced 54.39%	52,445 $2.22 Million
Q2 2024 Jul 31, 2024	SELL	$41.71 - $52.9 $51,720 - $65,596	-1,240 Reduced 1.07%	114,990 $5.28 Million
Q1 2024 May 06, 2024	BUY	$32.52 - $52.33 $466,174 - $750,150	14,335 Added 14.07%	116,230 $6.05 Million
Q4 2023 Feb 06, 2024	SELL	$30.85 - $37.09 $653,865 - $786,122	-21,195 Reduced 17.22%	101,895 $3.63 Million
Q3 2023 Nov 02, 2023	SELL	$31.69 - $39.25 $1.57 Million - $1.95 Million	-49,675 Reduced 28.75%	123,090 $4.13 Million
Q2 2023 Aug 11, 2023	BUY	$29.0 - $38.37 $849,555 - $1.12 Million	29,295 Added 20.42%	172,765 $6.49 Million
Q1 2023 May 05, 2023	BUY	$23.85 - $31.34 $3.42 Million - $4.5 Million	143,470 New	143,470 $4.21 Million
Q3 2022 Nov 01, 2022	SELL	$22.62 - $32.54 $1.57 Million - $2.25 Million	-69,205 Reduced 51.32%	65,652 $1.52 Million
Q2 2022 Aug 03, 2022	BUY	$22.88 - $39.45 $39,856 - $68,721	1,742 Added 1.31%	134,857 $3.4 Million
Q1 2022 May 12, 2022	BUY	$31.69 - $43.29 $4.22 Million - $5.76 Million	133,115 New	133,115 $5.09 Million
Q4 2021 Feb 04, 2022	SELL	$35.2 - $52.6 $1.63 Million - $2.43 Million	-46,185 Closed	0 $0
Q3 2021 Nov 03, 2021	SELL	$46.35 - $59.75 $586,095 - $755,538	-12,645 Reduced 21.49%	46,185 $2.25 Million
Q2 2021 Aug 16, 2021	SELL	$47.2 - $67.81 $6.83 Million - $9.81 Million	-144,715 Reduced 71.1%	58,830 $3.09 Million
Q1 2021 May 12, 2021	BUY	$30.93 - $59.48 $2.81 Million - $5.4 Million	90,800 Added 80.54%	203,545 $11.3 Million
Q4 2020 Feb 10, 2021	BUY	$18.53 - $31.5 $2.09 Million - $3.55 Million	112,745 New	112,745 $3.48 Million

Others Institutions Holding VCEL

# of Institutions

291

Shares Held

52.1M

Call Options Held

36.7K

Put Options Held

6.4K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $1.93B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lisanti Capital Growth, LLC with notifications on news.

Account

Lisanti Capital Growth, LLC Vericel Corp Transaction History